EU-LIFE, released today a statement with its recommendations for next framework Programme for Research & Innovation, FP9. Strong key message is: to drive European leadership in innovation, boost excellent ground breaking research in combination with professional technology transfer.
Giulio Superti-Furga, Scientific Director of the EU-LIFE member institute CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Professor for Medical Systems Biology of the Medical University of Vienna has been appointed Member of the Scientific Council of the ERC for a function period of 4 years.
ERC President, Jean-Pierre Bourguignon was the key note speaker at the 2016 EU-LIFE Community Meeting, which was held 2-3 November at The Netherlands Cancer Institute (NKI) in Amsterdam. The President of the European Research Council joined EU-LIFE community to discuss the challenging perspectives of research in Europe including the next framework programme (FP9) and overall science policy.
EU-LIFE which spans over 7200 researchers in 13 European countries is committed to international collaboration, with exchange of talent in order to facilitate scientific excellence. Therefore to create consortia based on excellence, we will continue to collaborate with our colleagues in the UK following the referendum on EU membership.
EU-LIFE nominated for the new Open Science Policy Platform at the European Commission. The Directorate-General for Research and Innovation at the European Commission established a Commission Advisory Group to provide advice about the development and implementation of open science policy in Europe.
The EU-LIFE Scientific Workshop organized by the translational research working group of the EU-LIFE institutes took place from May 12-13, 2016 at CeMM in Vienna. Following successful meetings on “Biology of Cancer” (2014, CRG) and “Epigenetics and Disease” (2015, BRIC), this year’s topic was on "Inflammation and Immunity in Health and Disease". Three sessions explored autoimmunity, T-cells in cancer immunology, and innate pathways in cancer immunology.